Stakeholders Welcome European TSE Directive, Relax MDD Review Concerns
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers of devices incorporating tissues or derivatives from animals should prepare for a six-month implementation period following year-end publication of a European transmissible spongiform encephalopathy (TSE) directive
You may also be interested in...
EU Tissue Laws: TSE Directive Issued, Industry Awaits Additional HTP Rules
European Union member states must adopt and publish the European Commission's new directive on medical devices using tissues of animal origin by Jan. 1, 2004
EU Tissue Laws: TSE Directive Issued, Industry Awaits Additional HTP Rules
European Union member states must adopt and publish the European Commission's new directive on medical devices using tissues of animal origin by Jan. 1, 2004
EU Firms Back MDD, Public Health Shift; Class IIb, Transparency Issues Linger
European industry leaders support shifting medical device oversight within the European Commission from the directorate general for industry (DG Enterprise) to DG Sanco, the committee responsible for health and consumer protection